Objective: Lateral pelvic lymph node (LPLN) metastases are an important cause of
preventable local failure in rectal cancer. The aim of this study was to evaluate clinical and …

Purpose We aimed to evaluate the surgicopathological outcomes of lateral pelvic lymph
node dissection (LPLD) and long-term oncological outcomes of selective LPLD after …

Purpose The prognostic significance and treatment of lateral pelvic lymph node metastasis
(mLPLN) in rectal cancer patients receiving neoadjuvant chemoradiotherapy (nCRT) are not …

Aim It is still controversial whether the addition of lateral pelvic lymph node (LPN) dissection
(LPND) to total mesorectal excision (TME) can provide a survival benefit after neoadjuvant …

Background Lateral lymph node (LLN) metastasis is a major cause of local recurrence of
advanced rectal cancer. Although there is much controversy between Western and Eastern …

Abstract Background and Objectives There is no consensus on the safety and indications of
lateral pelvic lymph node dissection (LPND) for patients with clinical lateral pelvic node …

Background Synchronous lateral pelvic lymph node (LPLN) involvement occurs in a
significant number of patients with rectal cancer. The aim of this study is to determine the …

Background Although lateral pelvic node dissection (LPND) is recommended for rectal
cancer with clinically metastatic lateral pelvic lymph nodes (LPNs), LPNs may respond to …

Purpose The significance of lateral pelvic lymph nodes (LPLN) in rectal cancer remains
unclear. The purpose of this study was to determine the outcome of patients with LPLNs …

Purpose Lateral pelvic lymph node metastasis occurs in 15 to 20% of patients with locally
advanced low rectal cancer which increases risk of local recurrence and reduced survival …